The Use of Konjac Glucomannan Hydrolysates (GMH) to Improve the Health of the Skin and Reduce Acne Vulgaris (original) (raw)

[1]

Leyden JJ, Therapy for acne vulgaris. N. Engl. J. Med.,336:1156-1162, 1997

[2]

Goldgar C, Keahey DJ, Houchins J, Treatment options for acne rosacea. Am. Fam. Physician,80:461-468, 2009

[3]

Dréno B, Khammar A, Acne – Inflammatory affection of pilo sebaceous follicle: The most frequent cutaneous illness of modern time. Business briefing: European Pharmaco. Therapy (Report) 130-135, 2003

[4]

Witkowski JA, Parish LC, The assessment of acne: An evaluation of grading and lesion counting in the measurement of acne. Clin. Dermatol.,22:394-397, 2004

[5]

Burke BM, Cunliffe WJ, The assessment of acne vulgaris – the Leeds technique. _Br. J. Dermatol.,_111:83-92, 1984

[6]

Anand Kumar BH, Sachidanand YN, Treatment of acne vulgaris with new polyherbal formulations, Clarina cream and Purim tablets. _Indian J. Dermatol.,_46:138-141, 2001

[7]

Goulden V, Guidelines for the management of acne vulgaris in adolescents. Paediatr. Drugs,5:301-313, 2003

[8]

Johnson BA, Nunley JR, Use of systemic agents in the treatment of acne vulgaris. Am. Fam. Physician, 62:1823-1830, 2000

[9]

Goodman G, Managing acne vulgaris effectively. Aust. Fam. Physician, 35:705-708, 2006

[10]

Eady EA, Gloor M, Leyden JJ, Propionibacterium acnes Resistance: A Worldwide Problem.Dermatol., 206:54-56, 2003

[11]

Al-Ghazzewi FH, Khanna S, Tester RF, Piggott J, The potential use of konjac glucomannan hydrolysate as a prebiotic_._ J. Sci. Food Agric., 87:1758–1766, 2007

[12]

Elamir AA, Tester RF, Al-Ghazzewi FH, Kaal H, Ghalbon, AA, Elmegrahai NA, Piggott J, Effects of konjac glucomannan hydrolysates on the gut microflora of mice. Nutr. Food Sci., 38:422-429, 2008

[13]

Swanson KS, Grrieshop CM, Flickinger EA, Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Healy H-P, Dawson, KA, Merchen, NR, Fahey GC, Supplemental fructooligosaccharides and mannanoligo-saccharides influence immune function, lleal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. _J. Nutr.,_132:980-989, 2002

[14]

Torrecillas S, Makol A, Caballero MJ, Montero D, Robaina L, Real F, Sweetman J, Tort L, Izquierdo MS, Immune stimulation and improved infection resistance in European sea bass (Dicentrarchuslabrax) fed mannan oligosaccharides. Fish Shellfish Immunol., 23:969-981, 2007

[15]

Yamada K, Tokunaga Y, Ikeda A, Ohkura K, Kaku-Ohkura S, Mamiya, S. Lim BO, Tachibana H, Effect of dietary fibre on the lipid metabolism and immune function of aged Sprague-Dawley rats. _Biosci. Biotechnol. Biochem.,_67:429-433, 2003

[16]

Akiyama H, Oono T, Huh WK, Yamasaki O, Akagi Y, Uemura H, Yamada T, Iwatsuki K, Actions of gluco-oligosaccharide against Staphylococcus aureus. _J. Dermatol.,_29:580-586, 2002

[17]

Al-Ghazzewi FH, Tester RF, Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnesin vitro. Int. J. Cosmet. Sci., 32:139-142, 2010

[18]

Gibson GR, McCartney AL, Rastall RA, Prebiotics and resistance to gastrointestinal infections. Br. J. Nutr., 93:S31-34, 2005

[19]

Adityan B, Kumari R, Thappa DM, Scoring systems in acne vulgaris. _Indian J. Dermatol. Venereol. Leprol.,_75:323-326, 2009

[20]

Tucker SB, Tausend R, Cochran R, Flannigan SA, Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br. J. Dermatol.,110:487-492, 2006

[21]

Eady EA, Cove JH, Holland KT, Cunliffe WJ, Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure_._ Br. J. Dermatol., 121:51-57, 1989

[22]

Law MPM, Chuh AAT, Lee A, Molinari N, Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin. Exp. Dermatol.,35:16-21, 2010

[23]

Zaenglein AL, Making the case for early treatment of acne. _Clin. Pediatrics,_49:54-59, 2010

[24]

Chroni E, Monastirli A, Tsambaos D, Neuromuscular adverse effects associated with systemic retinoid dermatotherapy monitoring and treatment algorithm for Clinicians. Drug Safety,33:25-34, 2010

[25]

Berardesca E, Abril E, Serio M, Cameli, N, Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin. _Int. J. Cosmet. Sci.,_31:271-277, 2008

[26]

Suzuki H, Oomizu S, Yanase Y, Onishi N, Uchida K, Mihara S, Ono K, Kameyoshi Y, Hide M, Hydrolysed konjac glucomannan suppresses IgE production in mice B cells. Int. Arch. Allergy Immunol., 152:122-130, 2010